An 8-person AI startup had built products that regulated industries wanted to buy. Private equity firms, law firms, financial services companies, and healthcare organizations were actively evaluating them. Two prospects had already made their requirement explicit: no SOC 2, no deal. This was not a speculative compliance investment. It was a prerequisite to closing pipeline that already existed. The startup needed to go from zero compliance infrastructure to audit-ready, fast, and with enough credibility that the resulting certifications would actually hold up in enterprise procurement.
[ The Problem ]
Selling into regulated industries without a single compliance certification
The startup had no policies, no audit history, and a workforce composed entirely of contractors. Every target customer segment required compliance certifications as a baseline condition for vendor selection. Without SOC 2 and HIPAA, the company was systematically excluded from its own target market — not occasionally, but on every enterprise conversation.
Two active prospects had made the requirement concrete. Each compliance-gated deal represented material revenue for a company at this stage. The cost of inaction was not theoretical — it was measured in deals already stalled and a go-to-market motion that could not scale into the verticals the business was built to serve.
[ What they needed ]
Before selecting a compliance platform, the team needed to:
- Achieve SOC 2 and HIPAA certification with zero existing compliance infrastructure
- Produce audit reports that enterprise buyers in regulated industries would actually accept
- Navigate a contractor-only workforce with no HRIS and no prior audit history
- Resolve compliance coverage questions for no-code automation tools in their stack
- Manage upfront cost constraints without sacrificing audit quality
- Move fast enough to unblock two active customer prospects already requesting certifications
[ Why Drata won ]
Selected over Scrut, the AICPA-accredited audit pathway reframed the pricing conversation entirely — a cheaper report that enterprise buyers might reject was not actually cheaper.
Audit credibility was the entire business case: The startup was not buying compliance software — it was buying compliance reports that enterprise customers in regulated industries would accept. Scrut's non-accredited audit pathway introduced downstream acceptance risk that undermined the whole investment. Drata's AICPA accreditation removed that risk.
CAP addressed a starting-point problem Scrut could not: A company with no policies, no FTEs, and no audit history needed guided implementation. The Compliance Accelerator Program gave the founder confidence that the team could actually reach audit-ready — not just access a platform and figure it out alone.
Monthly payment structure eliminated the cash flow barrier: A bootstrapped startup cannot easily absorb a large upfront commitment. Structuring the contract as monthly payments converted a potential deal-stopper into a manageable operating expense without reducing the total contract value.
Relationship continuity during a five-week stall preserved the win: When the buyer deprioritized compliance mid-evaluation, consistent low-pressure engagement kept Drata positioned as the front-runner. When the founder was ready to move, Drata was still the credible choice — and he was willing to advocate internally for the premium.
[ How Drata solved it ]
Drata's compliance automation platform gave the team a structured path from zero to audit-ready, with native integrations covering their entire infrastructure stack — AWS, Google Workspace, and GitHub — reducing manual evidence collection to a minimum for their core environment.
The Compliance Accelerator Program (CAP) addressed the most acute gap: a company with no policies, no prior audit history, and no dedicated compliance staff needed guided implementation, not just software. CAP provided the hands-on support structure that a self-serve platform could not replicate.
HIPAA coverage was added alongside SOC 2, allowing both certifications to advance in parallel rather than sequentially. Risk Management and Vendor Risk Management modules extended the compliance foundation beyond the immediate audit scope, building infrastructure that would support the company's regulated-industry sales motion as it scaled.
Critically, Drata's AICPA-accredited audit pathway meant the resulting SOC 2 report would carry the credibility required by enterprise procurement teams — directly addressing the risk that a non-accredited report might be questioned or rejected by the very customers the certification was meant to unlock.
[ Before and after Drata ]
Before Drata, two active enterprise prospects were stalled and every regulated-industry conversation hit the same wall: no SOC 2, no HIPAA, no path forward. After, the startup entered its first audit cycle with a defined timeline, AICPA-accredited audit coverage, and compliance certifications advancing as a scheduled deliverable rather than a distant aspiration.
[ Business outcome ]
With Drata in place, the startup entered its first SOC 2 and HIPAA audit cycle with a defined implementation path and the guided support needed to reach the finish line despite starting from scratch.
The two active prospects that had made certification a prerequisite were no longer blocked — the compliance program was underway and the timeline was credible enough to keep those conversations alive. The AICPA-accredited audit pathway ensured the resulting reports would be accepted by the regulated-industry buyers the business depends on.
For a company at this stage, the commercial logic was straightforward: every compliance-gated deal that could now advance represented a multiple of the platform investment. The startup had converted a structural go-to-market blocker into a scheduled deliverable.